Omeros Corporation — Quarterly Cash Flow (NASDAQ:OMER) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Total assets 313.33 M277.08 M235.16 M200.57 M185.71 M Total liabilities 248.18 M181.21 M246.68 M240.79 M244.81 M Total equity 154.17 M182.61 M213.55 M228.69 M220.48 M Total liabilities & shareholders' equities 313.33 M277.08 M235.16 M200.57 M185.71 M Total debt ————— Net debt —————

뉴스

오메로스, YARTEMLEA 첫 상업 선적 시작에 주가 상승

Omeros stock rises as first commercial YARTEMLEA shipments begin

Omeros begins commercial distribution of TA-TMA treatment Yartemlea

Omeros VP Borges sells $750k in shares

Omeros Corporation (OMER) Discusses FDA Approval and Commercialization Plans for YARTEMLEA in TA-TMA Treatment Transcript

Omeros Gets FDA Approval for YARTEMLEA as First Therapy for TA-TMA

Omeros: Why The Novo Nordisk Deal Is More Important Than FDA Approval (NASDAQ:OMER)

Biohaven, Omeros And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Andersen Group (NYSE:ANDG), Biohaven (NYSE:BHVN)

Why Davis Commodities Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - AlphaTON Capital (NASDAQ:ATON), Biohaven (NYSE:BHVN)

수요일 주목받은 주식: 나이키, 오메로스, 마이크론, 인텔 및 다이나백스

NKE, OMER, MU, INTC, DVAX: 5 Trending Stocks Today - Nike (NYSE:NKE)

Omeros: Stock Pops On Yartemlea Approval, Longer-Term Upside Likely (NASDAQ:OMER)